Subtopic Deep Dive

Total Mesorectal Excision
Research Guide

What is Total Mesorectal Excision?

Total Mesorectal Excision (TME) is a standardized surgical technique involving sharp dissection along the mesorectal fascia to remove the rectum and its surrounding mesorectum in rectal cancer treatment.

TME reduces local recurrence rates from over 30% to under 10% when standardized (Heald et al., 1993, 1741 citations). Preoperative radiotherapy combined with TME further lowers recurrence risk (Kapiteijn et al., 2001, 4177 citations). Over 20,000 papers reference TME techniques across open, laparoscopic, and robotic approaches.

15
Curated Papers
3
Key Challenges

Why It Matters

TME standardization cut rectal cancer local recurrence from 38% to 8% in national audits, establishing it as the global standard for rectal cancer surgery (Swedish Rectal Cancer Trial, 1997, 2502 citations). Combined with short-course radiotherapy, TME improves 5-year survival to 58% versus 48% without (Kapiteijn et al., 2001). ERAS protocols incorporating TME reduce hospital stays by 2-3 days and complications by 30% (Gustafsson et al., 2012, 2168 citations). Laparoscopic TME matches open surgery outcomes at 3 years (Jayne et al., 2007, 1502 citations). JSCCR guidelines mandate TME for mid/low rectal cancers (Watanabe et al., 2017, 2472 citations).

Key Research Challenges

Standardizing Surgical Technique

Achieving consistent mesorectal plane dissection varies by surgeon experience, with incomplete resections in 20-30% of cases raising recurrence risk (Kapiteijn et al., 2001). National training programs reduced variability but quality metrics remain debated (Heald et al., 1993). Laparoscopic conversion rates reach 25% (Jayne et al., 2007).

Laparoscopic vs Open Outcomes

Laparoscopic TME shows noninferior 3-year cancer outcomes but higher conversion and anterior resection risks (Jayne et al., 2007, 1502 citations). Long-term circumferential margin positivity equals open at 10% (Jayne et al., 2007). Surgeon learning curve exceeds 60 cases.

Neoadjuvant Therapy Integration

Preoperative radiotherapy with TME halves local recurrence but adds toxicity without survival gain from added chemotherapy (Bosset et al., 2006, 2685 citations). Optimal sequencing and patient selection for short-course versus long-course regimens remain unresolved (Glimelius et al., 2013).

Essential Papers

1.

Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal et al. · 2001 · New England Journal of Medicine · 4.2K citations

Short-term preoperative radiotherapy reduces the risk of local recurrence in patients with rectal cancer who undergo a standardized total mesorectal excision.

2.

Chemotherapy with Preoperative Radiotherapy in Rectal Cancer

Jean-François Bosset, Laurence Collette, G. Calais et al. · 2006 · New England Journal of Medicine · 2.7K citations

In patients with rectal cancer who receive preoperative radiotherapy, adding fluorouracil-based chemotherapy preoperatively or postoperatively has no significant effect on survival. Chemotherapy, r...

3.

Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer

Swedish Rectal Cancer Trial · 1997 · New England Journal of Medicine · 2.5K citations

A short-term regimen of high-dose preoperative radiotherapy reduces rates of local recurrence and improves survival among patients with resectable rectal cancer.

4.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer

Toshiaki Watanabe, Kei Muro, Yoichi Ajioka et al. · 2017 · International Journal of Clinical Oncology · 2.5K citations

Japanese mortality due to colorectal cancer is on the rise, surpassing 49,000 in 2015. Many new treatment methods have been developed during recent decades. The Japanese Society for Cancer of the C...

5.

Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society Recommendations

Ulf Gustafsson, Michael J. Scott, W. Schwenk et al. · 2012 · World Journal of Surgery · 2.2K citations

Abstract Background This review aims to present a consensus for optimal perioperative care in rectal/pelvic surgery, and to provide graded recommendations for items for an evidenced‐based enhanced ...

6.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Yojiro Hashiguchi, Kei Muro, Yutaka Saitō et al. · 2019 · International Journal of Clinical Oncology · 1.9K citations

Abstract The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was...

7.

Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS<sup>®</sup>) Society Recommendations: 2018

Ulf Gustafsson, Michael J. Scott, Martin Hübner et al. · 2018 · World Journal of Surgery · 1.9K citations

Abstract Background This is the fourth updated Enhanced Recovery After Surgery (ERAS ® ) Society guideline presenting a consensus for optimal perioperative care in colorectal surgery and providing ...

Reading Guide

Foundational Papers

Start with Heald et al. (1993) for TME technique origin, then Kapiteijn et al. (2001) for RT combination evidence establishing global standard, Swedish Rectal Cancer Trial (1997) for survival data.

Recent Advances

Study JSCCR 2019 (Hashiguchi et al., 1878 citations) for updated mandates, Gustafsson ERAS 2018 (1855 citations) for perioperative optimization, Jayne CLASICC 3-year (2007) for laparoscopic validation.

Core Methods

Sharp mesofascial plane dissection under 2x magnification; total mesorectal mobilization to levators; high vascular ligation; specimen-oriented pathology. Laparoscopic: medial-to-lateral; robotic: Firefly fluorescence.

How PapersFlow Helps You Research Total Mesorectal Excision

Discover & Search

PapersFlow's Research Agent uses searchPapers to retrieve Kapiteijn et al. (2001) as the top-cited TME paper with 4177 citations, then citationGraph reveals 15,000+ forward citations linking to laparoscopic trials like Jayne et al. (2007). exaSearch uncovers ERAS protocols (Gustafsson et al., 2012), while findSimilarPapers expands to robotic TME comparisons.

Analyze & Verify

Analysis Agent applies readPaperContent to extract survival curves from Swedish Rectal Cancer Trial (1997), then verifyResponse with CoVe cross-checks recurrence rates across Kapiteijn (2001) and Bosset (2006). runPythonAnalysis computes meta-analysis hazard ratios from Kaplan-Meier data using pandas, with GRADE grading assigning high evidence to TME standardization (Kapiteijn et al., 2001).

Synthesize & Write

Synthesis Agent detects gaps in robotic TME long-term data versus laparoscopic standards (Jayne et al., 2007), flagging contradictions in margin positivity. Writing Agent uses latexEditText for surgical workflow diagrams, latexSyncCitations for JSCCR guidelines (Hashiguchi et al., 2019), and latexCompile for ERAS protocol supplements, with exportMermaid for recurrence rate flowcharts.

Use Cases

"Compare 5-year local recurrence rates in TME with and without preoperative RT from RCTs."

Research Agent → searchPapers('TME recurrence radiotherapy RCT') → readPaperContent(Kapiteijn 2001, Swedish 1997) → Analysis Agent → runPythonAnalysis(pandas meta-analysis) → GRADE high evidence report with HR=0.46.

"Draft LaTeX figure comparing open vs laparoscopic TME margins from CLASICC trial."

Research Agent → findSimilarPapers(Jayne 2007) → Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure('forest plot margins') → latexSyncCitations → latexCompile → PDF output.

"Find Python code for mesorectal volume analysis from TME imaging papers."

Research Agent → exaSearch('TME mesorectal volume segmentation code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(volume calculator) → validated script.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ TME papers: searchPapers → citationGraph(Swedish Trial) → DeepScan 7-steps with CoVe verification → structured report on recurrence meta-analysis. DeepScan analyzes neoadjuvant integration: readPaperContent(Bosset 2006) → runPythonAnalysis(toxicity stats) → GRADE → critique methodology. Theorizer generates hypotheses on robotic TME superiority from Jayne (2007) gaps → exportMermaid decision trees.

Frequently Asked Questions

What defines Total Mesorectal Excision?

TME requires sharp dissection in the holy plane between mesorectal fascia and pelvic sidewall to achieve complete mesorectal removal without breaching the fascia (Heald et al., 1993). Quality graded by pathology: complete, near-complete, or incomplete.

What are main TME surgical approaches?

Open TME remains gold standard; laparoscopic TME equivalent at 3 years but 17% conversion rate (Jayne et al., 2007); robotic emerging for narrow pelvis. JSCCR 2019 mandates TME for T2+ rectal cancers (Hashiguchi et al., 2019).

Key papers establishing TME?

Heald et al. (1993, Lancet, 1741 citations) introduced mesorectal excision; Kapiteijn et al. (2001, NEJM, 4177 citations) proved RT+TME superiority; Swedish Trial (1997, 2502 citations) showed survival benefit.

Open problems in TME research?

Optimal neoadjuvant regimens without survival gain from chemo (Bosset 2006); robotic cost-effectiveness; AI-assisted plane detection; long-term bowel function post-TME.

Research Colorectal Cancer Surgical Treatments with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Total Mesorectal Excision with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers